Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 29, 2025	Jun. 30, 2024	Jun. 29, 2025	Jun. 30, 2024
Income Statement [Abstract]
Net revenue	[1]	$ 170,532	$ 143,900	$ 332,592	$ 308,486
Cost of revenue		106,554	112,077	212,288	228,426
Gross profit		63,978	31,823	120,304	80,060
Operating expenses:
Research and development		20,845	19,851	39,154	40,078
Sales and marketing		31,053	29,757	59,094	60,286
General and administrative		20,683	19,186	38,753	37,253
Litigation reserves, net		75	8,200	38	8,230
Restructuring and other charges		862	1,688	5,604	2,720
Total operating expenses		73,518	78,682	142,643	148,567
Loss from operations		(9,540)	(46,859)	(22,339)	(68,507)
Other income, net	[2]	3,976	2,713	12,147	5,563
Loss before income taxes		(5,564)	(44,146)	(10,192)	(62,944)
Provision for income taxes		864	1,029	2,270	881
Net loss		$ (6,428)	$ (45,175)	$ (12,462)	$ (63,825)
Net loss per share
Basic		$ (0.22)	$ (1.56)	$ (0.43)	$ (2.19)
Diluted		$ (0.22)	$ (1.56)	$ (0.43)	$ (2.19)
Weighted average shares used to compute net loss per share:
Basic		28,911	28,883	28,815	29,136
Diluted		28,911	28,883	28,815	29,136

[1] No individual foreign country represented more than 10% of the Company’s total net revenue in the periods presented.

[2] Amounts included interest income of $3.1 million and $6.4 million for the three and six months ended June 29, 2025, respectively, and $2.5 million and $5.0 million for the three and six months ended June 30, 2024, respectively. Amounts also included gain/(loss), net from derivatives not designated as hedging instruments of $(2.1) million and $(3.1) million for the three and six months ended June 29, 2025, respectively, and $0.6 million and $2.1 million for the three and six months ended June 30, 2024, respectively. For the six months ended June 29, 2025, the amount also included proceeds of $4.7 million from a sale of patents.